vigiVec through the Research Corner lens

Research / 15 November 2023

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Communicating pharmacovigilance research is not an easy task, especially when it takes you on a deep dive into the multi-dimensional vector space. Luckily, the second short film in our Research Corner series is here to guide you through data-driven vector representations of adverse events and drugs – in under four minutes.

Joana Félix, medical informatician at UMC and co-author of the research poster and forthcoming report on their neural network model, vigiVec, sat down with us to explain how it can be harnessed to predict co-reported drugs and adverse events on reports in VigiBase. The completed film can be viewed below:



Joana said this about her experience: “As a researcher, I don't often step into the spotlight. Research Corner provides a different and interesting platform to communicate science. It turned the challenging task of breaking down intricate concepts, such as vector representations in a multi-dimensional space, for a pharmacovigilance audience into a fun experience.”

Transforming complex methods into easily digestible and compelling shorts is just one of the series' aims. It also complements existing materials on our channels and the academic reports themselves and captures the people behind the innovative research taking place at UMC. We look forward to seeing who takes a seat in front of the camera in the next episode of Research Corner – stay tuned!


A spotlight on the Research Corner

Research Corner – UMC’s Science in the Spotlight focuses on our research and researchers, with each episode in the series featuring a recently completed study: what was investigated and why, what were the findings, and what it means for pharmacovigilance. Watch the complete series on our YouTube channel.


Read more:

Artificial intelligence applied: data-driven vector representations of adverse events and drugs in pharmacovigilance [Scientific poster]

Data-driven Discovery

Our first Research Corner episode – UMC science gets personal

Found in space – New method reveals related drug and reaction terms

Shannen Young
Communications Officer, UMC

You may also like

Looking beyond age to understand adverse reaction risk in older patients

When it comes to pharmacovigilance in older patients, age alone is insufficient as a measure of adverse reaction risk. Here is what we should consider instead.

Research / 13 May 2024

When medicines change our behaviour – New podcast out now

Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?

Research / 02 May 2024

Updating our approach to study adverse reactions

The traditional “drug-event combination” approach is too simplistic for complex side effects such as behavioural changes. We must adjust our methodology to address this intricacy.

Research / 29 May 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more